PT-141 10mg
PT-141 10mg
Regular price
$38.00
Regular price
Sale price
$38.00
Unit price
per
Shipping calculated at checkout.
Couldn't load pickup availability
 |
|
| Clinical data | |
|---|---|
| Pronunciation | /ˌbrɛmɪˈlænətaɪd/ ⓘ |
| Other names | PT-141; Rekynda, bremelanotide acetate (USAN US) |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a619054 |
| License data | |
| Routes of administration |
Subcutaneous[1] |
| Drug class | Central nervous system agent |
| ATC code | |
| Pharmacokinetic data | |
| Bioavailability | SCTooltip Subcutaneous injection: ~100%[1] |
| Protein binding | 21%[1] |
| Metabolism | Hydrolysis of peptide bonds[1] |
| Elimination half-life | 2.7 hours[1] |
| Excretion |
Urine: 64.8% Feces: 22.8% |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C50H68N14O10 |
| Molar mass | 1025.182 g·mol−1 |
| 3D model (JSmol) | |
| (verify) | |
**The information provided is intended solely for educational purposes and should not be considered a replacement for professional medical advice. Additionally, it is important to note that research chemicals are intended solely for laboratory study by professional researchers and are not intended for human consumption.**
